Saturday, January 28, 2023


Delfi Diagnostics Selected as the Liquid Biopsy Partner for 4-IN-THE-LUNG-RUN: A Large-Scale European Lung Cancer Screening Study

Delfi Diagnostics, a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring, has been selected...

BD, Labcorp Collaborate to Develop Flow Cytometry-Based Companion Diagnostics

BD (Becton, Dickinson and Company), a leading global medical technology company, announced a collaboration agreement with Labcorp, a leading global life sciences company, creating...

Kent NHS Trusts in the UK to Modernize Patient Diagnostics With Sectra in a Multi-Hospital Collaborative Environment

International medical imaging IT and cybersecurity company Sectra has signed a contract with Kent and Medway Medical Imaging Consortium. The new agreement will help...

Seegene unveils world’s first commercialized ‘3 Ct’ PCR assay

Seegene Inc., South Korea's leading molecular diagnostics (MDx) company, announced the development of the world's first commercialized PCR assay applying '3 Ct' technology. The...

Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms

Abbott announced it has received clearance from the U.S. Food and Drug Administration for the EnSite™ X EP System with EnSite Omnipolar Technology (OT),...

Hot Topics